Depends on how much they spend!!
If growth in elite wearables continues to be strong and with a full year of XOS revenue factored in I think revenue could be around 80m for FY18. This off a growth in FY18 of 35% for wearables, 11.5% for XOS and around 3m revenue from prosumer. Certainly hoping they can outperform this...
I think spending in product development and sales and marketing for the new prosumer rollout will still be significant so we are likely to be in the dark on this until the Nov agm.
Depreciation & amortisation costs are going to keep our NPAT negative, just how much will be the key...not going to see a strong SP recovery for a while yet if another CR is needed.
- Forums
- ASX - By Stock
- Prosumer revenue
Depends on how much they spend!! If growth in elite wearables...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.97 |
Change
-0.005(0.25%) |
Mkt cap ! $515.2M |
Open | High | Low | Value | Volume |
$1.95 | $2.00 | $1.89 | $1.350M | 696.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 86 | $1.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.98 | 14147 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 86 | 1.960 |
2 | 3500 | 1.950 |
1 | 2000 | 1.945 |
3 | 7800 | 1.940 |
1 | 2000 | 1.935 |
Price($) | Vol. | No. |
---|---|---|
1.980 | 14147 | 3 |
1.985 | 2000 | 1 |
1.990 | 2000 | 1 |
1.995 | 2759 | 2 |
2.000 | 6875 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online